Lake Street analyst Jacob Stephan maintains Arlo Technologies (NYSE:ARLO) with a Buy and raises the price target from $25 to $26.
RANCHO PALOS VERDES, CALIF. — The purchase funnel has become a loop. And AI is increasingly deciding which brands show up along the way. For automotiv...
Coeur Mining remains a Strong Buy despite Q3 setbacks, with strong free cash flow, upside to intrinsic value, and growth optionality. See more on CDE ...
Biglari: Q3 Earnings Snapshot
4 days agoSAN ANTONIO (AP) — SAN ANTONIO (AP) — Biglari Holdings Inc. (BH) on Friday reported third-quarter net income of $1 million, after reporting a loss in ...
OLDWICK, N.J., November 06, 2026--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of "a+" (...
Data centers run on debt. That was a problem for bonds this year — and it’s only going to get worse.
4 days agoAI debt issuance this year overwhelmed investor portfolios, and has disappointed from a performance perspective. The funding need won’t get any better...
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Kailey Lein...
With the election behind us, investors can have a lot more confidence in what the future holds.
GRINDR INC (GRND) delivered earnings and revenue surprises of -25.00% and +3.67%, respectively, for the quarter ended September 2026. Do the numbers h...
Lake Street analyst Frank Takkinen maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price target from $12 to $20.
Truist chief investment officer and chief market strategist Keith Lerner sits down with Yahoo Finance Markets and Data Editor Jared Blikre to share hi...
Elon Musk Says SpaceX Sales Are ‘Exploding’—and Forecasts Revenue Twice Wall Street’s Estimate
4 days agoRon Baron’s annual investment conference often includes a conversation with the SpaceX CEO Baron calls “Starman.”
Lake Street analyst Tyler Burmeister maintains Alpha & Omega (NASDAQ:AOSL) with a Buy and lowers the price target from $58 to $40.
Intel Corporation (INTC) stock’s deep sell-off shows signs of an overreaction, in my view, as the market may be overlooking the progress the chipmaker...
US equity indexes slumped this week after a post-election rout in big tech as investors expect data
US equity indexes were mixed Friday after October nonfarm payrolls expanded more than twice as expec
Lake Street analyst Thomas Flaten maintains Biodesix (NASDAQ:BDSX) with a Buy and lowers the price target from $40 to $30.
Uber Technologies Inc. revealed that artificial intelligence agents generated just 504 orders and rides during Halloween week, compared with approxima...
Medicus Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
4 days agoCompany Highlights CD228V as its Principal Development Priority, Proposed SPAC Business Combination at ~ $135 Million Valuation for SkinJect® and Teve...
Loading...
